Records containing: Salivary Gland Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-20PET Imaging Study of 68Ga-FAPI-46 Biodistribution in Cancer Patients
-
CLINICAL_TRIALS study record update · 2026-04-13HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers
-
CLINICAL_TRIALS study record update · 2026-04-02Cancer Hospital, Chinese Academy of Medical Sciences/National Cancer Center of China
-
CLINICAL_TRIALS study record update · 2025-12-31Phase II Trial of Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma: Big Ten Cancer Research Consortium BTCRC-HN17-111
-
CLINICAL_TRIALS study record update · 2025-09-22A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-12PET Imaging Study of 68Ga-FAPI-46 Biodistribution in Cancer Patients
-
CLINICAL_TRIALS study record update · 2023-12-29Dual Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Salivary Gland Cancers
-
CLINICAL_TRIALS study record update · 2023-08-03A Phase I-II, FIH Study of A166 in Locally Advanced/Metastatic Solid Tumors Expressing Human Epidermal Growth Factor Receptor 2 (HER2) or Are HER2 Amplified That Did Not Respond or Stopped Responding to Approved Therapies
-
CLINICAL_TRIALS study record update · 2022-02-22Phase 2 Study of 9-ING-41, a Glycogen Synthase Kinase 3 Beta (GSK 3β) Inhibitor, Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma
-
CLINICAL_TRIALS study record update · 2022-01-11A Phase II, Multicenter, Non Randomized, Open Label Study of Nivolumab In Recurrent and/or Metastatic Salivary Gland Carcinoma of the Head and Neck
-
CLINICAL_TRIALS study record update · 2021-09-21Cell-free Tumor DNAand HPV-DNA in Blood Samples From Newly Diagnosed Patients With Head and Neck Cancer
-
CLINICAL_TRIALS study record update · 2019-10-29Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma